Prostate Cancer Germany Drug Forecasts and Treatment Analysis to

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Germany Compression Therapy Market Outlook to 2020

Germany Compression Therapy Market Outlook to 2020

  • $ 2 500
  • Industry report
  • by Global Data
  • October 2014
  • 68 pages

Germany Compression Therapy Market Outlook to 2020 Summary GlobalData's new report, "Germany Compression Therapy Market Outlook to 2020", provides key market data on the Germany Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in ...

Industries: Therapy | Countries: Germany

EU5 Compression Therapy Market Outlook to 2020

EU5 Compression Therapy Market Outlook to 2020

  • $ 3 000
  • Industry report
  • by Global Data
  • October 2014
  • 273 pages

EU5 Compression Therapy Market Outlook to 2020 Summary GlobalData's new report, "EU5 Compression Therapy Market Outlook to 2020", provides key market data on the EU5 Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) ...

Industries: Therapy | Countries: France, Germany, Italy, United Kingdom, Spain, Europe

Respiratory Therapy News OCTOBER 2014

Respiratory Therapy News OCTOBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • October 2014
  • 28 pages

Industry Trend Analysis - Respiratory Market Stratification Inevitable, Augmented By ERS Revelations Industry Trend Analysis - Teva Follows De-Diversification Trend With Focus On CNS/Respiratory Industry Trend Analysis - Race For First US IPF Treatment Is A Dead Heat Industry Brief - Novavax Initiates ...

Industries: Therapy | Countries: United States, Greece, Germany, Japan, Europe, World, Asia

Asthma and COPD Therapies Market Forecast 2014-2024: Opportunities for Leading Companies

Asthma and COPD Therapies Market Forecast 2014-2024: Opportunities for Leading Companies

  • $ 2 902
  • Industry report
  • by Visiongain
  • October 2014
  • 335 pages

Report Details Asthma and COPD therapies - new study showing you trends, R&D progress, and predicted revenues Where's the asthma and COPD therapies market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 335-page ...

Industries: Therapy | Countries: World, Japan, United States, Mexico, Russian Federation, Germany, India, China

Physiotherapy Equipment Market by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), Applications (Pediatric, Musculoskeletal) & by End Users (Hospitals), Advanced technologies - Global Forecast to 2019

Physiotherapy Equipment Market by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), Applications (Pediatric, Musculoskeletal) & by End Users (Hospitals), Advanced technologies - Global Forecast to 2019

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • September 2014
  • 168 pages

Developing markets such as Middle East, Australia, New Zealand, China, India, and Malaysia are lucrative markets for physiotherapy equipment, owing to favorable government incentives and developing healthcare infrastructure. The report segments the global physiotherapy equipment market by product, application, ...

Industries: Therapy | Countries: World, North America, Europe, Germany, Canada, United States, China, Australia

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

  • $ 4 995
  • Industry report
  • by GBI Research
  • July 2014
  • 72 pages

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, has released its latest research: “Critical Care Therapeutics in Major Developed Markets to ...

Industries: Therapy | Countries: France, Canada, Japan, Spain, Italy, Germany, United States, Europe, United Kingdom, World

MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 4 495
  • Industry report
  • by VacZine Analytics Group Of Assay Advantage Ltd
  • July 2014
  • 60 pages

Allergy or Allergic rhinitis is caused by sensitivity to a number of environmental factors including grass, tree and weed pollens, house dust mite and cat dander. Prevalence in adults can range from 17 - 40% and is region/climate dependent. For those patients failing to respond to symptomatic treatments ...

Industries: Therapy | Countries: Japan, World, Europe, France, Netherlands, United States, Spain, Italy, Germany, United Kingdom, Denmark

Global Proton Therapy Outlook 2018

Global Proton Therapy Outlook 2018

  • $ 2 000
  • Industry report
  • by RNCOS
  • June 2014
  • 90 pages

Proton Therapy, the new kid on the block for cancer treatment, has garnered worldwide attention in the past few years. Due to its ability to deliver higher doses of radiation to the targeted areas without affecting the healthy tissues, it is being promulgated as the next big thing in the world of cance ...

Industries: Therapy | Countries: Germany, China, Japan, World

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 4 995
  • Industry report
  • by GBI Research
  • June 2014
  • 112 pages

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Summary GBI Research, a leading business intelligence provider, has released its latest research report, “Glioblastoma Multiforme Therapeutics ...

Industries: Therapy | Countries: World, Germany, Japan, United States, Europe, North America, Canada, Spain, Italy, France, United Kingdom

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

  • $ 4 995
  • Industry report
  • by GBI Research
  • April 2014
  • 122 pages

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading business intelligence provider, has released its latest research,‘Pancreatic Adenocarcinoma Therapeutics ...

Industries: Therapy | Countries: World, Japan, Canada, Europe, United States, Spain, Italy, France, Germany, United Kingdom, North America

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.